• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测食管胃交界腺癌近端切缘阳性及评估安全切缘距离的术前模型的开发与验证

Development and validation of a preoperative model for predicting positive proximal margins in adenocarcinoma of the esophagogastric junction and assessing safe margin distance.

作者信息

Guo Zhenjiang, Wang Ning, Zhao Guangyuan, Du Liqiang, Cui Zhaobo, Liu Fangzhen

机构信息

Department of Gastrointestinal, Hengshui People's Hospital, Hengshui, Hebei, China.

Department of Respiratory and Critical Care Medicine, Hengshui People's Hospital, Hengshui, Hebei, China.

出版信息

Front Oncol. 2024 Dec 10;14:1503728. doi: 10.3389/fonc.2024.1503728. eCollection 2024.

DOI:10.3389/fonc.2024.1503728
PMID:39720570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11666492/
Abstract

OBJECTIVE

To develop and validate a model for preoperative prediction of positive proximal margins for adenocarcinoma of the esophagogastric junction (AEG) by transabdominal approach, and to analyze the safe margin distances for patients with different risks of positive proximal margins.

MATERIALS AND METHODS

A retrospective analysis was performed on 284 AEG patients who underwent surgery via the transabdominal approach at Hengshui People's Hospital between January 2017 and December 2023. Patients were divided into a training set (=201, first five years) and a test set (=83, last two years). Clinicopathologic factors potentially influencing margin status were collected. The synthetic minority oversampling technique (SMOTE) was applied to address class imbalance in the training set. Two nomogram models were developed: one based on the original training set and the other using the SMOTE dataset. The model's performance was compared using the test set, with the area under the curve (AUC) used to evaluate discrimination and the Hosmer-Lemeshow test used for model fit. The best-performing model was used to calculate total scores for the entire cohort, and the optimal cutoff value was determined via the ROC curve. Patients were classified into low- and high-risk groups based on the total score, and optimal margin distances were determined using Youden's index.

RESULTS

The model developed using the SMOTE dataset showed superior AUC for predicting positive proximal margins in the test set compared to the model based on the original training set (0.814 0.780). Independent predictors of positive proximal margins included Borrmann classification, Lauren classification, cT stage, tumor differentiation, and Siewert classification. The Hosmer-Lemeshow test showed a good model fit (χ² = 5.397, = 0.612). Using a cutoff total score of 206.811, patients were divided into low-risk (score < 206.811) and high-risk (score ≥ 206.811) groups, with an AUC of 0.788. For the low-risk group, a proximal margin distance of 2.75 cm yielded an AUC of 0.824, with a sensitivity of 54.5%, specificity of 97.9%, and a Youden's index of 0.524. For the high-risk group, a margin distance of 3.85 cm provided an AUC of 0.813, sensitivity of 73.1%, specificity of 80.0%, and a Youden's index of 0.531.

CONCLUSIONS

The nomogram may offer a valuable preoperative tool for assessing the risk of positive proximal margins in AEG patients. While it holds the potential to inform surgical decision-making and help determine appropriate margin distances, further validation in larger and more diverse cohorts is needed to confirm its clinical utility.

摘要

目的

建立并验证一种经腹入路术前预测食管胃交界腺癌(AEG)近端切缘阳性的模型,并分析不同近端切缘阳性风险患者的安全切缘距离。

材料与方法

对2017年1月至2023年12月在衡水市人民医院经腹入路手术的284例AEG患者进行回顾性分析。患者分为训练集(=201例,前五年)和测试集(=83例,后两年)。收集可能影响切缘状态的临床病理因素。应用合成少数过采样技术(SMOTE)解决训练集中的类别不平衡问题。建立了两个列线图模型:一个基于原始训练集,另一个使用SMOTE数据集。使用测试集比较模型的性能,曲线下面积(AUC)用于评估鉴别能力,Hosmer-Lemeshow检验用于评估模型拟合度。使用表现最佳的模型计算整个队列的总分,并通过ROC曲线确定最佳截断值。根据总分将患者分为低风险和高风险组,并使用约登指数确定最佳切缘距离。

结果

与基于原始训练集的模型相比,使用SMOTE数据集开发的模型在测试集中预测近端切缘阳性的AUC更高(0.814对0.780)。近端切缘阳性的独立预测因素包括Borrmann分类、Lauren分类、cT分期、肿瘤分化和Siewert分类。Hosmer-Lemeshow检验显示模型拟合良好(χ² = 5.397,P = 0.612)。使用截断总分206.811,患者分为低风险(得分<206.811)和高风险(得分≥206.811)组,AUC为0.788。对于低风险组,近端切缘距离2.75 cm时AUC为0.824,敏感性为54.5%,特异性为97.9%,约登指数为0.524。对于高风险组,切缘距离3.85 cm时AUC为0.813,敏感性为73.1%,特异性为80.0%,约登指数为0.531。

结论

列线图可为评估AEG患者近端切缘阳性风险提供有价值的术前工具虽然它有可能为手术决策提供信息并帮助确定合适的切缘距离,但需要在更大和更多样化的队列中进行进一步验证以确认其临床实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/7ef9d6e735b2/fonc-14-1503728-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/bc6c5741a538/fonc-14-1503728-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/c1d23f3018d0/fonc-14-1503728-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/783680d0f96d/fonc-14-1503728-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/1c70b3eacaad/fonc-14-1503728-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/7ef9d6e735b2/fonc-14-1503728-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/bc6c5741a538/fonc-14-1503728-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/c1d23f3018d0/fonc-14-1503728-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/783680d0f96d/fonc-14-1503728-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/1c70b3eacaad/fonc-14-1503728-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dfa/11666492/7ef9d6e735b2/fonc-14-1503728-g005.jpg

相似文献

1
Development and validation of a preoperative model for predicting positive proximal margins in adenocarcinoma of the esophagogastric junction and assessing safe margin distance.用于预测食管胃交界腺癌近端切缘阳性及评估安全切缘距离的术前模型的开发与验证
Front Oncol. 2024 Dec 10;14:1503728. doi: 10.3389/fonc.2024.1503728. eCollection 2024.
2
[Predictive value of ventricular repolarization heterogeneity parameters for malignant arrhythmias in children with viral myocarditis].[心室复极异质性参数对病毒性心肌炎患儿恶性心律失常的预测价值]
Zhonghua Yi Xue Za Zhi. 2025 Mar 25;105(12):912-918. doi: 10.3760/cma.j.cn112137-20241115-02564.
3
A nomogram for predicting the risk of major postoperative complications for patients with meningioma.脑膜瘤患者术后主要并发症风险预测的列线图。
Neurosurg Rev. 2023 Oct 31;46(1):288. doi: 10.1007/s10143-023-02198-8.
4
Construction of a novel nomogram for predicting overall survival in patients with Siewert type II AEG based on LODDS: a study based on the seer database and external validation.基于LODDS构建预测Siewert II型AEG患者总生存期的新型列线图:一项基于SEER数据库及外部验证的研究
Front Oncol. 2024 Jun 7;14:1396339. doi: 10.3389/fonc.2024.1396339. eCollection 2024.
5
An intraoperative nomogram for predicting secondary margin positivity in breast conserving surgery utilizing frozen section analysis.一种利用冰冻切片分析预测保乳手术中切缘阳性的术中列线图。
Front Oncol. 2025 Jan 7;14:1366467. doi: 10.3389/fonc.2024.1366467. eCollection 2024.
6
Risk factors and prognostic analysis of microscopic positive esophageal margins after radical surgery for proximal gastric cancer.根治性手术后近端胃癌显微镜下食管切缘阳性的危险因素及预后分析。
BMC Gastroenterol. 2024 Nov 26;24(1):433. doi: 10.1186/s12876-024-03527-x.
7
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
8
Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.用于预测接受新辅助治疗和根治性手术的食管胃交界部Siewert II/III型腺癌患者无病生存期的列线图
Front Oncol. 2022 Jun 8;12:908229. doi: 10.3389/fonc.2022.908229. eCollection 2022.
9
The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram.基于CT的影像组学列线图预测食管胃交界腺癌中人表皮生长因子受体2状态的价值
Front Oncol. 2021 Oct 14;11:707686. doi: 10.3389/fonc.2021.707686. eCollection 2021.
10
Development and validation of a nomogram model to predict the risk of strangulated intestinal obstruction.预测绞窄性肠梗阻风险的列线图模型的开发与验证
Sci Rep. 2024 Dec 28;14(1):31049. doi: 10.1038/s41598-024-82131-1.

引用本文的文献

1
QUESTIONS REGARDING SAMPLING AND VALIDATION METHODS.关于抽样和验证方法的问题。
Shock. 2025 Jun 1;63(6):947. doi: 10.1097/SHK.0000000000002580. Epub 2025 Mar 31.

本文引用的文献

1
Prognostic Relevance of the Proximal Resection Margin Distance in Distal Gastrectomy for Gastric Adenocarcinoma.胃腺癌远端胃癌根治术中切缘距离的预后相关性。
Ann Surg Oncol. 2024 Oct;31(10):6900-6908. doi: 10.1245/s10434-024-15721-y. Epub 2024 Jul 5.
2
The role of length of oral resection margin and survival in esophageal cancer surgery after neoadjuvant therapy: A retrospective propensity score-matched study.新辅助治疗后食管癌手术中切缘长度与生存的关系:一项回顾性倾向评分匹配研究。
Surgery. 2024 Oct;176(4):1098-1103. doi: 10.1016/j.surg.2024.04.037. Epub 2024 Jun 28.
3
Prognostic Implications of Various Surgical Procedures and Postoperative Margin Status in Gastroesophageal Junction Tumors.
各种手术方式及切缘状态对胃食管交界部肿瘤的预后影响
Indian J Surg Oncol. 2024 Mar;15(1):12-17. doi: 10.1007/s13193-023-01821-w. Epub 2023 Sep 23.
4
[Chinese expert consensus on the surgical treatment for adenocarcinoma of esophagogastric junction (Edition 2024)].《中国食管胃交界腺癌外科治疗专家共识(2024年版)》
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Feb 25;27(2):109-126. doi: 10.3760/cma.j.cn441530-20231212-00213.
5
The Multidisciplinary Approach and Surgical Management of GE Junction Adenocarcinoma.胃食管交界腺癌的多学科治疗方法与手术管理
Cancers (Basel). 2024 Jan 9;16(2):288. doi: 10.3390/cancers16020288.
6
Treatment of gastric adenocarcinoma: A rapidly evolving landscape.胃腺癌的治疗:一个快速演变的领域。
Eur J Cancer. 2023 Dec;195:113370. doi: 10.1016/j.ejca.2023.113370. Epub 2023 Oct 17.
7
The correlation between the margin of resection and prognosis in esophagogastric junction adenocarcinoma.食管胃结合部腺癌的切缘与预后的相关性。
World J Surg Oncol. 2023 Oct 9;21(1):316. doi: 10.1186/s12957-023-03202-7.
8
[Skip metastasis at the esophageal resection margin in radical gastrectomy: clinical characteristics of 30 cases].[根治性胃癌切除术中食管切缘无转移:30例临床特征]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Jul 25;26(7):675-679. doi: 10.3760/cma.j.cn441530-20221206-00508.
9
Current status and future perspectives for the treatment of resectable locally advanced esophagogastric junction cancer: A narrative review.可切除局部进展期食管胃结合部癌的治疗现状及展望:一项叙述性综述。
World J Gastroenterol. 2023 Jun 28;29(24):3758-3769. doi: 10.3748/wjg.v29.i24.3758.
10
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review.食管胃交界部癌的管理:一项叙述性多学科综述
Cancers (Basel). 2023 May 3;15(9):2597. doi: 10.3390/cancers15092597.